Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 102.04
-0.64 (-0.62%)
At close: Aug 11, 2025, 5:30 PM CET
Paramount Global Market Cap
Gilead Sciences has a market cap or net worth of €127.57 billion as of August 13, 2025. Its market cap has increased by 44.35% in one year.
Market Cap
127.57B
Enterprise Value
142.04B
Revenue
24.58B
Ranking
n/a
PE Ratio
23.74
Stock Price
$102.04
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 127.57B, an increase of 65,493.92%. That is a compound annual growth rate of 21.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 127.57B | 14.73% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.44B |
| DiaSorin | 4.45B |
| Amplifon | 3.38B |
| EL.En. | 937.78M |
| Philogen | 871.17M |
| Safilo Group | 520.28M |
| GPI S.p.A. | 473.19M |
| Pharmanutra | 448.95M |